Condition: Hepatocellular Carcinoma · Sponsor: Inova Health Care Services
The purpose of this research is to see the effect of triplet therapy with atezolizumab, bevacizumab, and memantine in treatment of your hepatocellular carcinoma.
This description comes directly from the study's public registry record.
Keary Jane't · 571-472-4724 · keary.janet@inova.org
Elahe Mollapour · 571-472-4724 · elahe.mollapour@inova.org
Always discuss trial participation with your own doctor first.
| Inova Schar Cancer Institute - Fair Oaks | Fairfax, Virginia, United States | Recruiting |
| Inova Health Care Service | Falls Church, Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06789757